Coloplast is recognized globally for innovative product development. Our endourology portfolio is known for delivering minimally invasive, differentiated and clinically focused products to help improve outcomes in your stone management and benign prostatic hyperplasia (BPH) patients. We also offer education and training to advance your technique, and patient materials to inform your patients.
Kidney stone disease is one of the most common and most costly urological disorders in the United States. Coloplast offers a wide range of products to support a variety of treatment options.
Benign prostatic hyperplasia (BPH) is the most common prostate problem for men older than age 50.1 We develop products for minimally invasive treatments to help make your BPH procedures more efficient.